 | • レポートコード：MRC2-11QY12473 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は内耳炎のグローバル市場について調査・分析したレポートです。種類別（自己免疫性内耳炎、感染性内耳炎）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別内耳炎の競争状況、市場シェア ・世界の内耳炎市場：種類別市場規模 2015年-2020年（自己免疫性内耳炎、感染性内耳炎） ・世界の内耳炎市場：種類別市場規模予測 2021年-2026年（自己免疫性内耳炎、感染性内耳炎） ・世界の内耳炎市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の内耳炎市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の内耳炎市場分析：米国、カナダ ・ヨーロッパの内耳炎市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの内耳炎市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の内耳炎市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの内耳炎市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Sanofi、Teva Pharmaceutical、Mylan、Eli Lilly、Sun Pharmaceutical、Shandong Taihua、Cipla ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Labyrinthitis, also known as vestibular neuritis, is an inflammation of the inner earor the nerves that connect the inner ear to the brain due to a variety of reasons such as infection by measles, mumps, trauma, autoimmune etc.
Labyrinthitis shows various symptoms such as hearing loss, speech problems, double vision, abnormal gait, dizziness, nystagmus (rapid and undesired eye motion), vertigo, ringing in the ears, etc. Labyrinthitis is triggered by cold flu and occur as a single attack, or a series of attacks, which generally resolves on its own over three to six weeks.
Market Analysis and Insights: Global Labyrinthitis Market
The global Labyrinthitis market size is projected to reach US$ 1883.3 million by 2026, from US$ 1847 million in 2020, at a CAGR of 1.8%% during 2021-2026.
Global Labyrinthitis Scope and Market Size
Labyrinthitis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Labyrinthitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Sanofi
Teva Pharmaceutical
Mylan
Eli Lilly
Sun Pharmaceutical
Shandong Taihua
Cipla
Market segment by Type, the product can be split into
Autoimmune Labyrinthitis
Infective Labyrinthitis
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Labyrinthitis Revenue
1.4 Market by Type
1.4.1 Global Labyrinthitis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Autoimmune Labyrinthitis
1.4.3 Infective Labyrinthitis
1.5 Market by Application
1.5.1 Global Labyrinthitis Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Labyrinthitis Market Perspective (2015-2026)
2.2 Global Labyrinthitis Growth Trends by Regions
2.2.1 Labyrinthitis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Labyrinthitis Historic Market Share by Regions (2015-2020)
2.2.3 Labyrinthitis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Labyrinthitis Market Growth Strategy
2.3.6 Primary Interviews with Key Labyrinthitis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Labyrinthitis Players by Market Size
3.1.1 Global Top Labyrinthitis Players by Revenue (2015-2020)
3.1.2 Global Labyrinthitis Revenue Market Share by Players (2015-2020)
3.1.3 Global Labyrinthitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Labyrinthitis Market Concentration Ratio
3.2.1 Global Labyrinthitis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Labyrinthitis Revenue in 2019
3.3 Labyrinthitis Key Players Head office and Area Served
3.4 Key Players Labyrinthitis Product Solution and Service
3.5 Date of Enter into Labyrinthitis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Labyrinthitis Historic Market Size by Type (2015-2020)
4.2 Global Labyrinthitis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Labyrinthitis Market Size by Application (2015-2020)
5.2 Global Labyrinthitis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Labyrinthitis Market Size (2015-2020)
6.2 Labyrinthitis Key Players in North America (2019-2020)
6.3 North America Labyrinthitis Market Size by Type (2015-2020)
6.4 North America Labyrinthitis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Labyrinthitis Market Size (2015-2020)
7.2 Labyrinthitis Key Players in Europe (2019-2020)
7.3 Europe Labyrinthitis Market Size by Type (2015-2020)
7.4 Europe Labyrinthitis Market Size by Application (2015-2020)
8 China
8.1 China Labyrinthitis Market Size (2015-2020)
8.2 Labyrinthitis Key Players in China (2019-2020)
8.3 China Labyrinthitis Market Size by Type (2015-2020)
8.4 China Labyrinthitis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Labyrinthitis Market Size (2015-2020)
9.2 Labyrinthitis Key Players in Japan (2019-2020)
9.3 Japan Labyrinthitis Market Size by Type (2015-2020)
9.4 Japan Labyrinthitis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Labyrinthitis Market Size (2015-2020)
10.2 Labyrinthitis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Labyrinthitis Market Size by Type (2015-2020)
10.4 Southeast Asia Labyrinthitis Market Size by Application (2015-2020)
11 India
11.1 India Labyrinthitis Market Size (2015-2020)
11.2 Labyrinthitis Key Players in India (2019-2020)
11.3 India Labyrinthitis Market Size by Type (2015-2020)
11.4 India Labyrinthitis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Labyrinthitis Market Size (2015-2020)
12.2 Labyrinthitis Key Players in Central & South America (2019-2020)
12.3 Central & South America Labyrinthitis Market Size by Type (2015-2020)
12.4 Central & South America Labyrinthitis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Labyrinthitis Introduction
13.1.4 Merck Revenue in Labyrinthitis Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview
13.2.3 Sanofi Labyrinthitis Introduction
13.2.4 Sanofi Revenue in Labyrinthitis Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Teva Pharmaceutical
13.3.1 Teva Pharmaceutical Company Details
13.3.2 Teva Pharmaceutical Business Overview
13.3.3 Teva Pharmaceutical Labyrinthitis Introduction
13.3.4 Teva Pharmaceutical Revenue in Labyrinthitis Business (2015-2020)
13.3.5 Teva Pharmaceutical Recent Development
13.4 Mylan
13.4.1 Mylan Company Details
13.4.2 Mylan Business Overview
13.4.3 Mylan Labyrinthitis Introduction
13.4.4 Mylan Revenue in Labyrinthitis Business (2015-2020)
13.4.5 Mylan Recent Development
13.5 Eli Lilly
13.5.1 Eli Lilly Company Details
13.5.2 Eli Lilly Business Overview
13.5.3 Eli Lilly Labyrinthitis Introduction
13.5.4 Eli Lilly Revenue in Labyrinthitis Business (2015-2020)
13.5.5 Eli Lilly Recent Development
13.6 Sun Pharmaceutical
13.6.1 Sun Pharmaceutical Company Details
13.6.2 Sun Pharmaceutical Business Overview
13.6.3 Sun Pharmaceutical Labyrinthitis Introduction
13.6.4 Sun Pharmaceutical Revenue in Labyrinthitis Business (2015-2020)
13.6.5 Sun Pharmaceutical Recent Development
13.7 Shandong Taihua
13.7.1 Shandong Taihua Company Details
13.7.2 Shandong Taihua Business Overview
13.7.3 Shandong Taihua Labyrinthitis Introduction
13.7.4 Shandong Taihua Revenue in Labyrinthitis Business (2015-2020)
13.7.5 Shandong Taihua Recent Development
13.8 Cipla
13.8.1 Cipla Company Details
13.8.2 Cipla Business Overview
13.8.3 Cipla Labyrinthitis Introduction
13.8.4 Cipla Revenue in Labyrinthitis Business (2015-2020)
13.8.5 Cipla Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Labyrinthitis Key Market Segments
Table 2. Key Players Covered: Ranking by Labyrinthitis Revenue
Table 3. Ranking of Global Top Labyrinthitis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Labyrinthitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Autoimmune Labyrinthitis
Table 6. Key Players of Infective Labyrinthitis
Table 7. Global Labyrinthitis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Labyrinthitis Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Labyrinthitis Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Labyrinthitis Market Share by Regions (2015-2020)
Table 11. Global Labyrinthitis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Labyrinthitis Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Labyrinthitis Market Growth Strategy
Table 17. Main Points Interviewed from Key Labyrinthitis Players
Table 18. Global Labyrinthitis Revenue by Players (2015-2020) (Million US$)
Table 19. Global Labyrinthitis Market Share by Players (2015-2020)
Table 20. Global Top Labyrinthitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Labyrinthitis as of 2019)
Table 21. Global Labyrinthitis by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Labyrinthitis Product Solution and Service
Table 24. Date of Enter into Labyrinthitis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Labyrinthitis Market Size by Type (2015-2020) (Million US$)
Table 27. Global Labyrinthitis Market Size Share by Type (2015-2020)
Table 28. Global Labyrinthitis Revenue Market Share by Type (2021-2026)
Table 29. Global Labyrinthitis Market Size Share by Application (2015-2020)
Table 30. Global Labyrinthitis Market Size by Application (2015-2020) (Million US$)
Table 31. Global Labyrinthitis Market Size Share by Application (2021-2026)
Table 32. North America Key Players Labyrinthitis Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Labyrinthitis Market Share (2019-2020)
Table 34. North America Labyrinthitis Market Size by Type (2015-2020) (Million US$)
Table 35. North America Labyrinthitis Market Share by Type (2015-2020)
Table 36. North America Labyrinthitis Market Size by Application (2015-2020) (Million US$)
Table 37. North America Labyrinthitis Market Share by Application (2015-2020)
Table 38. Europe Key Players Labyrinthitis Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Labyrinthitis Market Share (2019-2020)
Table 40. Europe Labyrinthitis Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Labyrinthitis Market Share by Type (2015-2020)
Table 42. Europe Labyrinthitis Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Labyrinthitis Market Share by Application (2015-2020)
Table 44. China Key Players Labyrinthitis Revenue (2019-2020) (Million US$)
Table 45. China Key Players Labyrinthitis Market Share (2019-2020)
Table 46. China Labyrinthitis Market Size by Type (2015-2020) (Million US$)
Table 47. China Labyrinthitis Market Share by Type (2015-2020)
Table 48. China Labyrinthitis Market Size by Application (2015-2020) (Million US$)
Table 49. China Labyrinthitis Market Share by Application (2015-2020)
Table 50. Japan Key Players Labyrinthitis Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Labyrinthitis Market Share (2019-2020)
Table 52. Japan Labyrinthitis Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Labyrinthitis Market Share by Type (2015-2020)
Table 54. Japan Labyrinthitis Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Labyrinthitis Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Labyrinthitis Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Labyrinthitis Market Share (2019-2020)
Table 58. Southeast Asia Labyrinthitis Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Labyrinthitis Market Share by Type (2015-2020)
Table 60. Southeast Asia Labyrinthitis Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Labyrinthitis Market Share by Application (2015-2020)
Table 62. India Key Players Labyrinthitis Revenue (2019-2020) (Million US$)
Table 63. India Key Players Labyrinthitis Market Share (2019-2020)
Table 64. India Labyrinthitis Market Size by Type (2015-2020) (Million US$)
Table 65. India Labyrinthitis Market Share by Type (2015-2020)
Table 66. India Labyrinthitis Market Size by Application (2015-2020) (Million US$)
Table 67. India Labyrinthitis Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Labyrinthitis Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Labyrinthitis Market Share (2019-2020)
Table 70. Central & South America Labyrinthitis Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Labyrinthitis Market Share by Type (2015-2020)
Table 72. Central & South America Labyrinthitis Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Labyrinthitis Market Share by Application (2015-2020)
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Product
Table 77. Merck Revenue in Labyrinthitis Business (2015-2020) (Million US$)
Table 78. Merck Recent Development
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Product
Table 82. Sanofi Revenue in Labyrinthitis Business (2015-2020) (Million US$)
Table 83. Sanofi Recent Development
Table 84. Teva Pharmaceutical Company Details
Table 85. Teva Pharmaceutical Business Overview
Table 86. Teva Pharmaceutical Product
Table 87. Teva Pharmaceutical Revenue in Labyrinthitis Business (2015-2020) (Million US$)
Table 88. Teva Pharmaceutical Recent Development
Table 89. Mylan Company Details
Table 90. Mylan Business Overview
Table 91. Mylan Product
Table 92. Mylan Revenue in Labyrinthitis Business (2015-2020) (Million US$)
Table 93. Mylan Recent Development
Table 94. Eli Lilly Company Details
Table 95. Eli Lilly Business Overview
Table 96. Eli Lilly Product
Table 97. Eli Lilly Revenue in Labyrinthitis Business (2015-2020) (Million US$)
Table 98. Eli Lilly Recent Development
Table 99. Sun Pharmaceutical Company Details
Table 100. Sun Pharmaceutical Business Overview
Table 101. Sun Pharmaceutical Product
Table 102. Sun Pharmaceutical Revenue in Labyrinthitis Business (2015-2020) (Million US$)
Table 103. Sun Pharmaceutical Recent Development
Table 104. Shandong Taihua Company Details
Table 105. Shandong Taihua Business Overview
Table 106. Shandong Taihua Product
Table 107. Shandong Taihua Revenue in Labyrinthitis Business (2015-2020) (Million US$)
Table 108. Shandong Taihua Recent Development
Table 109. Cipla Business Overview
Table 110. Cipla Product
Table 111. Cipla Company Details
Table 112. Cipla Revenue in Labyrinthitis Business (2015-2020) (Million US$)
Table 113. Cipla Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Labyrinthitis Market Share by Type: 2020 VS 2026
Figure 2. Autoimmune Labyrinthitis Features
Figure 3. Infective Labyrinthitis Features
Figure 4. Global Labyrinthitis Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Labyrinthitis Report Years Considered
Figure 9. Global Labyrinthitis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Labyrinthitis Market Share by Regions: 2020 VS 2026
Figure 11. Global Labyrinthitis Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Labyrinthitis Market Share by Players in 2019
Figure 14. Global Top Labyrinthitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Labyrinthitis as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Labyrinthitis Revenue in 2019
Figure 16. North America Labyrinthitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Labyrinthitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Labyrinthitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Labyrinthitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Labyrinthitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Labyrinthitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Labyrinthitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…- 動物用自己免疫疾患検査の世界市場（～2026年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…
- 自己免疫疾患診断の世界市場（～2026年） The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific. In terms of geography, the Americas led the …
- 自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
- 抗感染症薬の世界市場（～2026年） Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro p…